HomeSWOBY • OTCMKTS
add
Swedish Orphan Biovitrum ADR
Nakaraang pagsara
$16.06
Sakop ng taon
$12.75 - $17.35
Market cap
113.87B SEK
Average na Volume
1.52K
P/E ratio
-
Dividend yield
-
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (SEK) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 7.78B | 12.79% |
Gastos sa pagpapatakbo | 3.41B | -3.26% |
Net na kita | -2.89B | -297.68% |
Net profit margin | -37.22 | -275.24% |
Kita sa bawat share | 6.05 | 40.37% |
EBITDA | 10.32B | 243.54% |
Aktuwal na % ng binabayarang buwis | 28.12% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (SEK) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.04B | 74.92% |
Kabuuang asset | 66.96B | -7.25% |
Kabuuang sagutin | 30.98B | -11.70% |
Kabuuang equity | 35.98B | — |
Natitirang share | 344.66M | — |
Presyo para makapag-book | 0.15 | — |
Return on assets | 10.33% | — |
Return on capital | 13.82% | — |
Cash Flow
Net change in cash
| (SEK) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -2.89B | -297.68% |
Cash mula sa mga operasyon | 1.84B | 53.21% |
Cash mula sa pag-invest | -2.70B | -22.57% |
Cash mula sa financing | 857.00M | -0.35% |
Net change in cash | -19.00M | 89.73% |
Malayang cash flow | 5.71B | 262.88% |
Tungkol
Swedish Orphan Biovitrum AB is an international biopharmaceutical company dedicated to treatments in the areas of haematology, immunology and specialty care, based in Stockholm, Sweden.
In 2020 it had a revenue of SEK 15.261 billion and 1,509 employees. Wikipedia
Itinatag
1939
Website
Mga Empleyado
1,890
